These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33966293)

  • 1. Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
    Jonsdottir G; Björkholm M; Turesson I; Hultcrantz M; Diamond B; Porwit A; Landgren O; Kristinsson SY
    Eur J Haematol; 2021 Aug; 107(2):275-282. PubMed ID: 33966293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).
    Mailankody S; Pfeiffer RM; Kristinsson SY; Korde N; Bjorkholm M; Goldin LR; Turesson I; Landgren O
    Blood; 2011 Oct; 118(15):4086-92. PubMed ID: 21795746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
    Koontz MZ; Horning SJ; Balise R; Greenberg PL; Rosenberg SA; Hoppe RT; Advani RH
    J Clin Oncol; 2013 Feb; 31(5):592-8. PubMed ID: 23295809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
    Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
    Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy-related myelodysplasia and acute myeloid leukemia.
    Bhatia S
    Semin Oncol; 2013 Dec; 40(6):666-75. PubMed ID: 24331189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
    Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
    Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
    Kaplan HG; Malmgren JA; Atwood MK
    BMC Cancer; 2011 Jun; 11():260. PubMed ID: 21693006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion 5q31 in patients with stable, melphalan-treated multiple myeloma.
    Amiel A; Fridman K; Elis A; Gaber E; Manor Y; Fejgin M; Lishner M
    Cancer Genet Cytogenet; 1999 Aug; 113(1):45-8. PubMed ID: 10459345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
    Kaplan H; Malmgren J; De Roos AJ
    Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.
    Rollison DE; Shain KH; Lee JH; Hampras SS; Fulp W; Fisher K; Al Ali NH; Padron E; Lancet J; Xu Q; Olesnyckyj M; Kenvin L; Knight R; Dalton W; List A; Komrokji RS
    Cancer Med; 2016 Jul; 5(7):1694-701. PubMed ID: 27098006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
    Metayer C; Curtis RE; Vose J; Sobocinski KA; Horowitz MM; Bhatia S; Fay JW; Freytes CO; Goldstein SC; Herzig RH; Keating A; Miller CB; Nevill TJ; Pecora AL; Rizzo JD; Williams SF; Li CY; Travis LB; Weisdorf DJ
    Blood; 2003 Mar; 101(5):2015-23. PubMed ID: 12393427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States.
    Shenolikar R; Durden E; Meyer N; Lenhart G; Moore K
    Gynecol Oncol; 2018 Nov; 151(2):190-195. PubMed ID: 30268525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
    Björkholm M; Derolf AR; Hultcrantz M; Kristinsson SY; Ekstrand C; Goldin LR; Andreasson B; Birgegård G; Linder O; Malm C; Markevärn B; Nilsson L; Samuelsson J; Granath F; Landgren O
    J Clin Oncol; 2011 Jun; 29(17):2410-5. PubMed ID: 21537037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
    Takahashi K; Wang F; Kantarjian H; Doss D; Khanna K; Thompson E; Zhao L; Patel K; Neelapu S; Gumbs C; Bueso-Ramos C; DiNardo CD; Colla S; Ravandi F; Zhang J; Huang X; Wu X; Samaniego F; Garcia-Manero G; Futreal PA
    Lancet Oncol; 2017 Jan; 18(1):100-111. PubMed ID: 27923552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
    Freedman RA; Seisler DK; Foster JC; Sloan JA; Lafky JM; Kimmick GG; Hurria A; Cohen HJ; Winer EP; Hudis CA; Partridge AH; Carey LA; Jatoi A; Klepin HD; Citron M; Berry DA; Shulman LN; Buzdar AU; Suman VJ; Muss HB
    Breast Cancer Res Treat; 2017 Jan; 161(2):363-373. PubMed ID: 27866278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.
    Ishii Y; Hsiao HH; Sashida G; Ito Y; Miyazawa K; Kodama A; Ohyashiki JH; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Jun; 167(2):131-7. PubMed ID: 16737912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk.
    Khan N; Patel D; Trivedi C; Kavani H; Pernes T; Medvedeva E; Lewis J; Xie D; Yang YX
    Am J Gastroenterol; 2021 Apr; 116(4):741-747. PubMed ID: 33982944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
    Poynter JN; Richardson M; Roesler M; Blair CK; Hirsch B; Nguyen P; Cioc A; Cerhan JR; Warlick E
    Int J Cancer; 2017 Jan; 140(1):23-33. PubMed ID: 27603749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.
    Nardi V; Winkfield KM; Ok CY; Niemierko A; Kluk MJ; Attar EC; Garcia-Manero G; Wang SA; Hasserjian RP
    J Clin Oncol; 2012 Jul; 30(19):2340-7. PubMed ID: 22585703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.